Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex

Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference...

Full description

Bibliographic Details
Main Authors: Daniele Marcotulli, Giorgia Fattorini, Luca Bragina, Jessica Perugini, Fiorenzo Conti
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/full
id doaj-20e079830db042a8a71149e78bf1e626
record_format Article
spelling doaj-20e079830db042a8a71149e78bf1e6262020-11-24T22:20:52ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022017-12-011110.3389/fncel.2017.00389296390Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral CortexDaniele Marcotulli0Giorgia Fattorini1Giorgia Fattorini2Luca Bragina3Luca Bragina4Jessica Perugini5Fiorenzo Conti6Fiorenzo Conti7Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyPresynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference was detected in SV2A protein levels in levetiracetam treated animals compared to controls, whereas levetiracetam post-transcriptionally decreased several vesicular proteins and increased LRRK2, without any change in mRNA levels. Analysis of SV2A interactome indicates that the presynaptic proteins regulation induced by levetiracetam reported here is mediated by this interactome, and suggests that LRRK2 plays a role in forging the pattern of effects.http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/fulllevetiracetamvesicular transport proteinsSV2Apresynaptic proteinsinteractomeLRRK2
collection DOAJ
language English
format Article
sources DOAJ
author Daniele Marcotulli
Giorgia Fattorini
Giorgia Fattorini
Luca Bragina
Luca Bragina
Jessica Perugini
Fiorenzo Conti
Fiorenzo Conti
spellingShingle Daniele Marcotulli
Giorgia Fattorini
Giorgia Fattorini
Luca Bragina
Luca Bragina
Jessica Perugini
Fiorenzo Conti
Fiorenzo Conti
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
Frontiers in Cellular Neuroscience
levetiracetam
vesicular transport proteins
SV2A
presynaptic proteins
interactome
LRRK2
author_facet Daniele Marcotulli
Giorgia Fattorini
Giorgia Fattorini
Luca Bragina
Luca Bragina
Jessica Perugini
Fiorenzo Conti
Fiorenzo Conti
author_sort Daniele Marcotulli
title Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
title_short Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
title_full Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
title_fullStr Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
title_full_unstemmed Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
title_sort levetiracetam affects differentially presynaptic proteins in rat cerebral cortex
publisher Frontiers Media S.A.
series Frontiers in Cellular Neuroscience
issn 1662-5102
publishDate 2017-12-01
description Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference was detected in SV2A protein levels in levetiracetam treated animals compared to controls, whereas levetiracetam post-transcriptionally decreased several vesicular proteins and increased LRRK2, without any change in mRNA levels. Analysis of SV2A interactome indicates that the presynaptic proteins regulation induced by levetiracetam reported here is mediated by this interactome, and suggests that LRRK2 plays a role in forging the pattern of effects.
topic levetiracetam
vesicular transport proteins
SV2A
presynaptic proteins
interactome
LRRK2
url http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/full
work_keys_str_mv AT danielemarcotulli levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT giorgiafattorini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT giorgiafattorini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT lucabragina levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT lucabragina levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT jessicaperugini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT fiorenzoconti levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
AT fiorenzoconti levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex
_version_ 1725773423367421952